Form 4: Douglas G. Cole, Director at Sana Biotechnology, Acquires Stock Options
SEC Form 4
Director Douglas G. Cole acquired stock options in Sana Biotechnology, Inc. exercisable for 54,278 shares of common stock.
Summary
- On June 6, 2024, Douglas G. Cole, a director of Sana Biotechnology, Inc., acquired stock options to purchase 54,278 shares of common stock.
- The exercise price of the options is $7.36 per share.
- The options vest and become exercisable on the earlier of June 6, 2025, or immediately prior to the 2025 annual meeting of stockholders, contingent upon continuous service to Sana Biotechnology, Inc.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to stock option grants, and does not contain information that would significantly shift investor sentiment.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's future performance, only details of the vesting schedule of the options.
Industry Context
This is a standard SEC Form 4 filing, reflecting a company director's acquisition of stock options, a common practice in executive compensation within the biotechnology industry.
Stakeholder Impact
- The acquisition of stock options by a director could align the director's interests more closely with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/06/2024 | Date of transaction: Douglas G. Cole acquired stock options. |
| 06/06/2025 | Earliest date the options vest and become exercisable, contingent on continuous service. |
| 06/05/2034 | Expiration date of the stock options. |
| 06/07/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.